🔎 Trials Near Me

Akèy › Twoub depresif majè › New York › Queens

Etid klinik pou Twoub depresif majè nan Queens, NY

6 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Ap rekriteFaz 2
  • Seaport Investigator Site, Cedarhurst · 7 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Cedarhurst · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06963021

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 2
  • Neurobehavioral Research, Inc., Cedarhurst · 7 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Aug 3, 2026 · NCT06547489

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Ap rekriteFaz 2
  • Neurobehavioral Research, Inc, Cedarhurst · 7 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Jul 27, 2026 · NCT07115329

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Glen Oaks · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Cedarhurst · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401

Etid Twoub depresif majè nan lòt vil

Lòt etid nan Queens

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.